Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

EG665186 Inhibitors

EG665186 inhibitors are a class of chemical compounds designed to specifically inhibit the activity of the EG665186 target, which is a molecule or protein involved in certain cellular processes. These inhibitors are characterized by their ability to bind to a particular binding site on the target molecule, altering its activity. The chemical structure of EG665186 inhibitors often includes heterocyclic rings and side chains that enhance binding affinity and specificity for the target. Their design is typically based on a thorough understanding of the target's three-dimensional structure, which allows for optimization of the inhibitor's size, shape, and electronic properties to achieve a high degree of selectivity and potency. The development of these compounds involves structure-activity relationship (SAR) studies to fine-tune their chemical features for the best possible interaction with the target.

In addition to their primary binding characteristics, EG665186 inhibitors may possess favorable physicochemical properties, such as optimal solubility, permeability, and metabolic stability, which are important for their function and activity within biological systems. These compounds are commonly studied in a variety of biochemical and cellular assays to evaluate their efficacy and selectivity in modulating the activity of the target protein. The inhibitors are often developed in a series of analogs, with each iteration bringing enhanced potency and specificity through modifications to functional groups and core scaffolds. Additionally, EG665186 inhibitors are evaluated for their binding kinetics, ensuring that they exhibit a suitable balance between on-rate and off-rate binding to their target. As a result, these inhibitors can serve as valuable tools for research applications to elucidate the function of the target protein in various cellular pathways and to investigate the biochemical mechanisms underlying its activity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Marimastat

154039-60-8sc-202223
sc-202223A
sc-202223B
sc-202223C
sc-202223E
5 mg
10 mg
25 mg
50 mg
400 mg
$165.00
$214.00
$396.00
$617.00
$4804.00
19
(1)

Inhibits matrix metalloproteinases (MMPs), which are involved in ECM remodeling, potentially affecting the matrix where Zpld2 is a constituent.

GM 6001

142880-36-2sc-203979
sc-203979A
1 mg
5 mg
$75.00
$265.00
55
(1)

Broad-spectrum MMP inhibitor, similar to Marimastat, which may affect ECM dynamics associated with Zpld2.

SB 225002

182498-32-4sc-202803
sc-202803A
1 mg
5 mg
$35.00
$100.00
2
(1)

Inhibits CXCR2, a receptor involved in neutrophil chemotaxis, potentially affecting processes where Zpld2 is involved in neutrophil migration.

Reparixin

266359-83-5sc-507446
5 mg
$76.00
(0)

Inhibits CXCR1/2, potentially affecting neutrophil migration and, by extension, processes in which Zpld2 is implicated.

BMS-345541

445430-58-0sc-221741
1 mg
$306.00
1
(1)

Inhibits NF-κB, which is involved in inflammatory responses and may regulate neutrophil migration where Zpld2 could be active.

Pertussis Toxin (islet-activating protein)

70323-44-3sc-200837
50 µg
$442.00
3
(1)

Inactivates G-proteins, potentially disrupting signaling processes at the cell surface where Zpld2 might be active.

NSC 23766

733767-34-5sc-204823
sc-204823A
10 mg
50 mg
$148.00
$597.00
75
(4)

Inhibits Rac1 activation, potentially impacting actin cytoskeleton rearrangement important for cell migration and Zpld2-related processes.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

PI3K inhibitor, affecting cell survival and migration that could intersect with the cellular location and processes of Zpld2.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$92.00
$223.00
30
(1)

Src family kinase inhibitor, which may affect signaling pathways involved in cell migration and adhesion where Zpld2 could play a role.